ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 191 filers reported holding ASCENDIS PHARMA A/S in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,607,556 | +4.9% | 754,032 | 0.0% | 4.45% | +1.0% |
| Q2 2023 | $67,297,356 | -16.8% | 754,032 | 0.0% | 4.41% | -14.8% |
| Q1 2023 | $80,847,311 | -24.8% | 754,032 | -14.4% | 5.17% | -19.0% |
| Q4 2022 | $107,572,104 | +108.4% | 880,800 | +76.2% | 6.38% | +112.6% |
| Q3 2022 | $51,612,000 | +11.1% | 499,824 | 0.0% | 3.00% | -22.4% |
| Q2 2022 | $46,464,000 | -20.8% | 499,824 | 0.0% | 3.87% | -13.1% |
| Q1 2022 | $58,659,000 | -12.8% | 499,824 | 0.0% | 4.45% | +13.3% |
| Q4 2021 | $67,241,000 | -15.6% | 499,824 | 0.0% | 3.93% | -16.7% |
| Q3 2021 | $79,667,000 | +16.0% | 499,824 | -4.2% | 4.72% | +19.2% |
| Q2 2021 | $68,659,000 | +2.1% | 521,923 | 0.0% | 3.96% | -2.2% |
| Q1 2021 | $67,265,000 | -63.7% | 521,923 | -53.0% | 4.04% | -63.3% |
| Q4 2020 | $185,105,000 | +8.1% | 1,109,874 | 0.0% | 11.02% | -13.2% |
| Q3 2020 | $171,276,000 | +4.3% | 1,109,874 | 0.0% | 12.70% | +22.7% |
| Q2 2020 | $164,150,000 | +31.3% | 1,109,874 | 0.0% | 10.35% | -10.5% |
| Q1 2020 | $124,983,000 | -19.1% | 1,109,874 | 0.0% | 11.56% | +3.9% |
| Q4 2019 | $154,406,000 | +44.4% | 1,109,874 | 0.0% | 11.13% | +15.1% |
| Q3 2019 | $106,903,000 | -15.6% | 1,109,874 | +0.9% | 9.67% | -16.9% |
| Q2 2019 | $126,645,000 | +7.8% | 1,099,824 | +10.1% | 11.64% | +2.7% |
| Q1 2019 | $117,528,000 | +25.2% | 998,538 | -33.4% | 11.33% | -3.1% |
| Q4 2018 | $93,883,000 | -46.6% | 1,498,538 | -39.6% | 11.70% | -25.3% |
| Q3 2018 | $175,698,000 | -46.7% | 2,479,514 | -50.0% | 15.66% | -25.5% |
| Q2 2018 | $329,876,000 | +103.4% | 4,959,028 | +100.0% | 21.04% | -24.5% |
| Q1 2018 | $162,160,000 | – | 2,479,514 | – | 27.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |